Insufficient scRNA-seq data for expression of IDO2 at single-cell level.
Insufficient scRNA-seq data for expression of IDO2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 939.63 | 222 / 226 | 16% | 0.75 | 66 / 406 |
thymus | 100% | 340.58 | 652 / 653 | 3% | 0.06 | 19 / 605 |
lung | 87% | 49.82 | 505 / 578 | 8% | 0.27 | 94 / 1155 |
spleen | 92% | 59.59 | 221 / 241 | 0% | 0 | 0 / 0 |
skin | 62% | 27.62 | 1116 / 1809 | 2% | 0.03 | 8 / 472 |
intestine | 40% | 17.32 | 384 / 966 | 1% | 0.02 | 4 / 527 |
bladder | 33% | 7.43 | 7 / 21 | 2% | 0.07 | 8 / 504 |
adipose | 21% | 6.35 | 255 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.76 | 6 / 29 |
kidney | 15% | 4.93 | 13 / 89 | 1% | 0.01 | 7 / 901 |
prostate | 13% | 3.91 | 32 / 245 | 1% | 0.14 | 3 / 502 |
esophagus | 11% | 2.43 | 156 / 1445 | 3% | 0.06 | 5 / 183 |
breast | 12% | 2.66 | 53 / 459 | 2% | 0.05 | 20 / 1118 |
adrenal gland | 12% | 2.29 | 30 / 258 | 0% | 0.01 | 1 / 230 |
stomach | 8% | 2.04 | 30 / 359 | 2% | 0.03 | 6 / 286 |
uterus | 4% | 4.86 | 6 / 170 | 6% | 0.30 | 26 / 459 |
peripheral blood | 9% | 1.90 | 85 / 929 | 0% | 0 | 0 / 0 |
pancreas | 7% | 1.32 | 22 / 328 | 2% | 0.02 | 3 / 178 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.05 | 2 / 45 |
ovary | 2% | 0.39 | 4 / 180 | 1% | 0.03 | 5 / 430 |
blood vessel | 2% | 0.72 | 32 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 0.14 | 16 / 2642 | 0% | 0.00 | 2 / 705 |
muscle | 0% | 0.11 | 4 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.07 | 4 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019441 | Biological process | tryptophan catabolic process to kynurenine |
GO_0002376 | Biological process | immune system process |
GO_0034354 | Biological process | 'de novo' NAD biosynthetic process from tryptophan |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0020037 | Molecular function | heme binding |
GO_0033754 | Molecular function | indoleamine 2,3-dioxygenase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004833 | Molecular function | tryptophan 2,3-dioxygenase activity |
Gene name | IDO2 |
Protein name | Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1) Alternative protein IDO2 |
Synonyms | INDOL1 |
Description | FUNCTION: Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway . Involved in immune regulation. May not play a significant role in tryptophan-related tumoral resistance . . |
Accessions | ENST00000502986.4 [Q6ZQW0-1] L8E9C5 Q6ZQW0 |